Results of low-dose carperitide infusion in high-risk patients undergoing coronary artery bypass grafting

Annals of Thoracic Surgery

Volumn 96, Issue 1, 2013, Pages 119-126

  Sezai, Akira ^a   Nakata, Kin Ichi ^a   Iida, Mitsuru ^a   Yoshitake, Isamu ^a   Wakui, Shinji ^a   Hata, Hirokaki ^a   Shiono, Motomi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; CREATININE; PLACEBO;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; FORWARD HEART FAILURE; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HEART RUPTURE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; LIVER DYSFUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SURGICAL MORTALITY;

AGED; ATRIAL NATRIURETIC FACTOR; CAUSE OF DEATH; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RENAL DIALYSIS; RISK FACTORS; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879691360     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.03.090     Document Type: Article

References (18)

1. S.A.M. Nashef, F. Roques, and P. Michel European System for Cardiac Operative Risk Evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
2. A. Sezai, M. Shiono, and Y. Orime Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery Ann Thorac Surg 69 2000 732 738
3. A. Sezai, M. Hata, and S. Wakui Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome Circ J 71 2007 1401 1407
4. A. Sezai, M. Hata, and T. Niino Influence of continuous infusion of low-dose human arterial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study J Am Coll Cardiol 54 2009 1058 1064
5. A. Sezai, M. Hata, and T. Niino Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery for left ventricular dysfunction J Am Coll Cardiol 55 2010 1844 1851
6. A. Sezai, M. Hata, and T. Niino Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting J Am Coll Cardiol 58 2011 897 901
7. P. Michel, F. Roques, S.A.M. Nashef The EuroSCORE Project Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23 2003 684 687
8. F. Nomura, N. Kurobe, and Y. Mori Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure-COMPASS: carperitide effects observed through monitoring dyspnea in acute decompensated heart failure study Circ J 72 2008 1777 1786
9. A.D. Struthers, and R.M. MacDonald Review of aldosterone- and angiotensin II-induced target organ damage and prevention Cardiovasc Res 61 2004 663 670
10. G. Güder, J. Bauersachs, and S. Frantz Complementary and incremental mortality risk predication by cortisol and aldosterone in chronic heart failure Circulation 115 2007 1754 1761
11. F. Beygui, J.P. Collet, and J.J. Benoliel High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction Circulation 114 2006 2604 2610
12. S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi Effect of atrial natriuretic peptide on left ventricular remodeling in patients with acute myocardial infarction Eur Heart J 29 2008 1485 1494
13. M. Kitakaze, M. Asakura, and J. Kim Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomized trials Lancet 370 2007 1483 1493
14. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, and K. Aaronson Short-term risk of death after treatment with nesiritide foe decompensated heart failure. A pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
15. A.F. Hernandez, C.M. O'Connor, and R.C. Starling Rationale and design of the acute study of clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF) Am Heart J 157 2009 271 272
16. C.M. O'Connor, R.C. Starling, and A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Eng J Med 365 2011 32 43
17. R.M. Mentzer Jr., M.C. Oz, and R.N. Sladen Effects of perioperaive nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial J Am Coll Cardiol 49 2007 716 726
18. H.H. Chen, T.M. Sundt, D.J. Cook, D.M. Heublein, and J.C. Burnett Jr. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study Circulation 116 2007 1134 1138 Technology